Advertisement

Topics

Azithromycin tied to poor airflow decline-free survival after HSCT

05:41 EDT 9 Aug 2017 | Medical Xpress

(HealthDay)—For patients after allogeneic hematopoietic stem cell transplant (HSCT), early administration of azithromycin is associated with worse airflow decline-free survival, according to a study published in the Aug. 8 issue of the Journal of the American Medical Association.

Original Article: Azithromycin tied to poor airflow decline-free survival after HSCT

NEXT ARTICLE

More From BioPortfolio on "Azithromycin tied to poor airflow decline-free survival after HSCT"

Quick Search
Advertisement
 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...